{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:16:36Z","timestamp":1787501796539,"version":"build-2736575974"},"reference-count":107,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,9,15]]},"DOI":"10.18632\/aging.203482","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T17:39:27Z","timestamp":1630690767000},"page":"21791-21806","source":"Crossref","is-referenced-by-count":20,"title":["Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer\u2019s disease: an adrenergic approach"],"prefix":"10.18632","volume":"13","author":[{"given":"Song","family":"Li","sequence":"first","affiliation":[{"name":"Liaoning Provincial Center for Clinical Research on Neurological Diseases, The First Affiliated Hospital, Dalian Medical University, Dalian 116021, China"},{"name":"Liaoning Provincial Key Laboratory for Research on the Pathogenic Mechanisms of Neurological Diseases, The First Affiliated Hospital, Dalian Medical University, Dalian 116021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Endemic and Ethnic Diseases, Guizhou Medical University, Guiyang 550004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021; 17:327-406. https:\/\/doi.org\/10.1002\/alz.12328.","DOI":"10.1002\/alz.12328"},{"key":"2","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1161\/01.str.0000014421.15948.67","article-title":"Alzheimer disease as a vascular disorder: nosological evidence.","volume":"3","author":"de la Torre","year":"2002","journal-title":"Stroke"},{"key":"3","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1161\/01.str.0000028987.97497.22","article-title":"Alzheimer disease as a vascular disorder: nosological evidence.","volume":"3","author":"Royall","year":"2002","journal-title":"Stroke"},{"key":"4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction-The disregarded partner of Alzheimer's disease.","volume":"1","author":"Ramirez","year":"2019","journal-title":"Alzheimers Dement"},{"key":"5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.","volume":"1","author":"Zlokovic","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"6","doi-asserted-by":"publisher","first-page":"e962","DOI":"10.1212\/WNL.0000000000010133","article-title":"Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance.","volume":"9","author":"Pillai","year":"2020","journal-title":"Neurology"},{"key":"7","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/ana.25905","article-title":"Alzheimer-Related Cerebrovascular Disease in Down Syndrome.","volume":"8","author":"Lee","year":"2020","journal-title":"Ann Neurol"},{"key":"8","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1002\/ctm2.397","article-title":"Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.","volume":"1","author":"Wang","year":"2021","journal-title":"Clin Transl Med"},{"key":"9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease.","volume":"1","author":"Montine","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1212\/WNL.0000000000009724","article-title":"ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project.","volume":"9","author":"Braber","year":"2020","journal-title":"Neurology"},{"key":"11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1440-1819.1991.tb01189.x","article-title":"Observations of microvessels in the brain with Alzheimer's disease by the scanning electron microscopy.","volume":"4","author":"Miyakawa","year":"1991","journal-title":"Jpn J Psychiatry Neurol"},{"key":"12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10456-017-9568-3","article-title":"Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe\/PS1dE9 model of Alzheimer's disease.","volume":"2","author":"Mitchell","year":"2017","journal-title":"Angiogenesis"},{"key":"13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10456-018-9608-7","article-title":"Peripheral post-ischemic vascular repair is impaired in a murine model of Alzheimer's disease.","volume":"2","author":"L\u00e9vy","year":"2018","journal-title":"Angiogenesis"},{"key":"14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/sj.jcbfm.9600570","article-title":"Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease.","volume":"2","author":"Stern","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41593-018-0329-4","article-title":"Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer's disease mouse models.","volume":"2","author":"Peyrounette","year":"2019","journal-title":"Nat Neurosci"},{"key":"16","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2967\/jnumed.108.051946","article-title":"Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern?","volume":"4","author":"Resnick","year":"2008","journal-title":"J Nucl Med"},{"key":"17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.neuroimage.2007.11.053","article-title":"Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer\u2019s dementia by perfusion-weighted magnetic resonance imaging.","volume":"4","author":"Cohnen","year":"2008","journal-title":"Neuroimage"},{"key":"18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00259-003-1277-z","article-title":"Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer\u2019s disease.","volume":"3","author":"Cabranes","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.neuroimage.2005.06.066","article-title":"The prediction of rapid conversion to Alzheimer\u2019s disease in mild cognitive impairment using regional cerebral blood flow SPECT.","volume":"2","author":"Asada","year":"2005","journal-title":"Neuroimage"},{"key":"20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neurobiolaging.2004.12.010","article-title":"Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.","volume":"2","author":"Perani","year":"2006","journal-title":"Neurobiol Aging"},{"key":"21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neurobiolaging.2009.01.013","article-title":"Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer\u2019s disease among patients with mild cognitive impairment.","volume":"3","author":"Dubois","year":"2011","journal-title":"Neurobiol Aging"},{"key":"22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease.","volume":"11","author":"Zlokovic","year":"2009","journal-title":"Acta Neuropathol"},{"key":"23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders.","volume":"1","author":"Zlokovic","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.","volume":"2","author":"Ringman","year":"2019","journal-title":"Nat Med"},{"key":"25","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1038\/ncomms3932","article-title":"Pericyte loss influences Alzheimer-like neurodegeneration in mice.","volume":"4","author":"Zlokovic","year":"2013","journal-title":"Nat Commun"},{"key":"26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.","volume":"1","author":"Zlokovic","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"27","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1111\/j.1582-4934.2008.00434.x","article-title":"A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer\u2019s disease brain.","volume":"1","author":"McLarnon","year":"2009","journal-title":"J Cell Mol Med"},{"key":"28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3389\/fnins.2019.01261","article-title":"A Pilot Study Investigating Changes in Capillary Hemodynamics and Its Modulation by Exercise in the APP-PS1 Alzheimer Mouse Model.","volume":"1","author":"Lesage","year":"2019","journal-title":"Front Neurosci"},{"key":"29","doi-asserted-by":"publisher","first-page":"H1559","DOI":"10.1152\/ajpheart.00129.2020","article-title":"Exercise training ameliorates cerebrovascular dysfunction in a murine model of Alzheimer's disease: role of the P2Y2 receptor and endoplasmic reticulum stress.","volume":"31","author":"Park","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"30","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ana.20493","article-title":"Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study.","volume":"5","author":"Breteler","year":"2005","journal-title":"Ann Neurol"},{"key":"31","doi-asserted-by":"publisher","first-page":"111184","DOI":"10.1016\/j.pscychresns.2020.111184","article-title":"Cerebrovascular pathology in Alzheimer's disease: Hopes and gaps.","volume":"30","author":"Westman","year":"2020","journal-title":"Psychiatry Res Neuroimaging"},{"key":"32","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1038\/ncomms11934","article-title":"Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.","volume":"7","author":"Evans","year":"2016","journal-title":"Nat Commun"},{"key":"33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","article-title":"Cerebrovascular disease in ageing and Alzheimer's disease.","volume":"13","author":"Miners","year":"2016","journal-title":"Acta Neuropathol"},{"key":"34","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1212\/wnl.56.11.1545","article-title":"Presenilin-1-associated abnormalities in regional cerebral perfusion.","volume":"5","author":"Pineda","year":"2001","journal-title":"Neurology"},{"key":"35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archneurol.2009.913","article-title":"APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.","volume":"6","author":"Resnick","year":"2010","journal-title":"Arch Neurol"},{"key":"36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.","volume":"58","author":"Benzinger","year":"2020","journal-title":"Nature"},{"key":"37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jalz.2018.08.002","article-title":"Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms.","volume":"1","author":"Blacker","year":"2019","journal-title":"Alzheimers Dement"},{"key":"38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1152\/physiol.00021.2016","article-title":"Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.","volume":"3","author":"Katusic","year":"2017","journal-title":"Physiology (Bethesda)"},{"key":"39","doi-asserted-by":"publisher","first-page":"40097","DOI":"10.1074\/jbc.M110.144626","article-title":"Brain endothelial cells produce amyloid {\u03b2} from amyloid precursor protein 770 and preferentially secrete the O-glycosylated form.","volume":"28","author":"Taniguchi","year":"2010","journal-title":"J Biol Chem"},{"key":"40","doi-asserted-by":"publisher","first-page":"eaav9518","DOI":"10.1126\/science.aav9518","article-title":"Amyloid \u03b2 oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes.","volume":"36","author":"Huang","year":"2019","journal-title":"Science"},{"key":"41","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1179\/016164101101198758","article-title":"Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production.","volume":"2","author":"Sutton","year":"2001","journal-title":"Neurol Res"},{"key":"42","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1097\/00001756-199704140-00014","article-title":"Cerebrovascular endothelial dysfunction mediated by \u03b2-amyloid.","volume":"8","author":"Thomas","year":"1997","journal-title":"Neuroreport"},{"key":"43","doi-asserted-by":"publisher","first-page":"H2417","DOI":"10.1152\/ajpheart.2001.281.6.H2417","article-title":"A beta-peptides enhance vasoconstriction in cerebral circulation.","volume":"28","author":"Iadecola","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/380168a0","article-title":"beta-Amyloid-mediated vasoactivity and vascular endothelial damage.","volume":"38","author":"Mullan","year":"1996","journal-title":"Nature"},{"key":"45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1006\/exnr.1997.6743","article-title":"Characteristics of the in vitro vasoactivity of \u03b2-amyloid peptides.","volume":"15","author":"Mullan","year":"1998","journal-title":"Exp Neurol"},{"key":"46","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1179\/016164103101201940","article-title":"Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer\u2019s disease: role of inflammation.","volume":"2","author":"Mullan","year":"2003","journal-title":"Neurol Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1161\/HYPERTENSIONAHA.113.01348","article-title":"Amyloid-\u03b2 peptides activate \u03b11-adrenergic cardiovascular receptors.","volume":"6","author":"Muller","year":"2013","journal-title":"Hypertension"},{"key":"48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0304-3940(98)00814-3","article-title":"Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo.","volume":"25","author":"Mullan","year":"1998","journal-title":"Neurosci Lett"},{"key":"49","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.","volume":"9","author":"Frangione","year":"2003","journal-title":"Nat Med"},{"key":"50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-1326-5-15","article-title":"Soluble amyloid-beta, effect on cerebral arteriolar regulation and vascular cells.","volume":"5","author":"Holtzman","year":"2010","journal-title":"Mol Neurodegener"},{"key":"51","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/STROKEAHA.112.670976","article-title":"Brain and circulating levels of A\u03b21-40 differentially contribute to vasomotor dysfunction in the mouse brain.","volume":"4","author":"Iadecola","year":"2013","journal-title":"Stroke"},{"key":"52","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1177\/0271678X16669956","article-title":"Epidermal growth factor prevents oligomeric amyloid-\u03b2 induced angiogenesis deficits in vitro.","volume":"3","author":"Tai","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"53","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1097\/00004647-200012000-00005","article-title":"Exogenous A\u03b21-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice.","volume":"2","author":"Iadecola","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10571-015-0256-9","article-title":"Endothelial dysfunction and amyloid-b-induced neurovascular alterations.","volume":"3","author":"Park","year":"2016","journal-title":"Cell Mol Neurobiol"},{"key":"55","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1038\/s41467-018-06301-2","article-title":"Apo\u03b54 disrupts neurovascular regulation and undermines white matter integrity and cognitive function.","volume":"9","author":"Iadecola","year":"2018","journal-title":"Nat Commun"},{"key":"56","doi-asserted-by":"publisher","first-page":"ra52","DOI":"10.1126\/scisignal.aaf6240","article-title":"Platelets contribute to amyloid-\u03b2 aggregation in cerebral vessels through integrin \u03b1IIb\u03b23-induced outside-in signaling and clusterin release.","volume":"9","author":"Elvers","year":"2016","journal-title":"Sci Signal"},{"key":"57","doi-asserted-by":"publisher","first-page":"E1289","DOI":"10.1073\/pnas.1710329115","article-title":"Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease.","volume":"11","author":"Hyman","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"58","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41593-020-0686-7","article-title":"Tau induces PSD95-neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration.","volume":"2","author":"Zhou","year":"2020","journal-title":"Nat Neurosci"},{"key":"59","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainresrev.2007.01.003","article-title":"Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases.","volume":"5","author":"Bari","year":"2007","journal-title":"Brain Res Rev"},{"key":"60","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neulet.2009.12.064","article-title":"Possible involvement of NO\/NOS signaling in hippocampal amyloid-beta production induced by transient focal cerebral ischemia in aged rats.","volume":"47","author":"Tang","year":"2010","journal-title":"Neurosci Lett"},{"key":"61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/01616412.1993.11740127","article-title":"Can disturbed brain microcirculation cause Alzheimer's disease?","volume":"1","author":"Mussivand","year":"1993","journal-title":"Neurol Res"},{"key":"62","doi-asserted-by":"publisher","first-page":"18727","DOI":"10.1073\/pnas.0606298103","article-title":"Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression.","volume":"10","author":"Song","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"63","doi-asserted-by":"publisher","first-page":"10873","DOI":"10.1074\/jbc.M608856200","article-title":"Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation.","volume":"28","author":"Zhang","year":"2007","journal-title":"J Biol Chem"},{"key":"64","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/jcbfm.2015.76","article-title":"Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease.","volume":"3","author":"Zlokovic","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"65","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fnagi.2015.00115","article-title":"Impaired A\u03b2 clearance: a potential link between atherosclerosis and Alzheimer\u2019s disease.","volume":"7","author":"Iadecola","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"66","doi-asserted-by":"publisher","first-page":"e3000313","DOI":"10.1371\/journal.pbio.3000313","article-title":"ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology.","volume":"1","author":"Yang","year":"2019","journal-title":"PLoS Biol"},{"key":"67","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1523\/JNEUROSCI.1230-20.2020","article-title":"Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.","volume":"4","author":"Conti","year":"2020","journal-title":"J Neurosci"},{"key":"68","doi-asserted-by":"publisher","first-page":"fcaa132","DOI":"10.1093\/braincomms\/fcaa132","article-title":"Cerebrovascular disease promotes tau pathology in Alzheimer's disease.","volume":"2","author":"Luchsinger","year":"2020","journal-title":"Brain Commun"},{"key":"69","doi-asserted-by":"publisher","first-page":"eaay6931","DOI":"10.1126\/scitranslmed.aay6931","article-title":"\u03b2-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3\u03b2\/tau cascade.","volume":"1","author":"Jiao","year":"2020","journal-title":"Sci Transl Med"},{"key":"70","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.2741\/4691","article-title":"Role of alpha1-adrenergic receptor antibodies in Alzheimer's disease.","volume":"2","author":"Bimmler","year":"2018","journal-title":"Front Biosci (Landmark Ed)"},{"key":"71","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.3390\/jcm9061919","article-title":"Immunoadsorption for Treatment of Patients with Suspected Alzheimer Dementia and Agonistic Autoantibodies against Alpha1a-Adrenoceptor-Rationale and Design of the IMAD Pilot Study.","volume":"9","author":"Wallukat","year":"2020","journal-title":"J Clin Med"},{"key":"72","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev.pa.33.040193.001331","article-title":"Pharmacologic and therapeutic applications of alpha 2-adrenoceptor subtypes.","volume":"3","author":"Hieble","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"73","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/01.hyp.32.2.311","article-title":"Expression of alpha2-adrenergic receptors in normal and atherosclerotic rabbit aorta.","volume":"3","author":"Gavras","year":"1998","journal-title":"Hypertension"},{"key":"74","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.bjp.0704149","article-title":"Role of the extracellular signal-regulated kinase (Erk) signal transduction cascade in alpha(2) adrenoceptor-mediated vasoconstriction in porcine palmar lateral vein.","volume":"13","author":"Roberts","year":"2001","journal-title":"Br J Pharmacol"},{"key":"75","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3389\/fneur.2020.01009","article-title":"The Application of Optical Coherence Tomography Angiography in Cerebral Small Vessel Disease, Ischemic Stroke, and Dementia: A Systematic Review.","volume":"1","author":"Wardlaw","year":"2020","journal-title":"Front Neurol"},{"key":"76","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.neurobiolaging.2015.05.002","article-title":"Dexmedetomidine increases tau phosphorylation under normothermic conditionsand","volume":"3","author":"Morin","year":"2015","journal-title":"Neurobiol Aging"},{"key":"77","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/sj.bjp.0706749","article-title":"Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation.","volume":"14","author":"Rossoni","year":"2006","journal-title":"Br J Pharmacol"},{"key":"78","doi-asserted-by":"publisher","first-page":"e91877","DOI":"10.1371\/journal.pone.0091877","article-title":"Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Gi\u03b1-coupled \u03b22-adrenoceptor signaling pathway.","volume":"9","author":"Rossoni","year":"2014","journal-title":"PLoS One"},{"key":"79","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1096\/fj.10-156661","article-title":"Binding of amyloid beta peptide to beta2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity.","volume":"2","author":"Xiang","year":"2010","journal-title":"FASEB J"},{"key":"80","doi-asserted-by":"publisher","first-page":"10298","DOI":"10.1074\/jbc.M112.415141","article-title":"\u03b22 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models.","volume":"28","author":"Xiang","year":"2013","journal-title":"J Biol Chem"},{"key":"81","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1093\/hmg\/ddu116","article-title":"Genetic suppression of \u03b22-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.","volume":"2","author":"Oddo","year":"2014","journal-title":"Hum Mol Genet"},{"key":"82","first-page":"319","article-title":"Vascular adrenoceptors: an update.","volume":"5","author":"Moura","year":"2001","journal-title":"Pharmacol Rev"},{"key":"83","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13195-021-00842-3","article-title":"Repurposing beta-3 adrenergic receptor agonists for Alzheimer's disease: beneficial effects in a mouse model.","volume":"1","author":"Calon","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"84","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1471-4159.2009.05800.x","article-title":"Rescue of Abeta(1-42)-induced memory impairment in day-old chick by facilitation of astrocytic oxidative metabolism: implications for Alzheimer's disease.","volume":"10","author":"Hertz","year":"2009","journal-title":"J Neurochem"},{"key":"85","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.neuropharm.2017.01.010","article-title":"Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.","volume":"11","author":"Shamloo","year":"2017","journal-title":"Neuropharmacology"},{"key":"86","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/acn3.57","article-title":"\u03b21-adrenergic receptor activation enhances memory in Alzheimer's disease model.","volume":"1","author":"Shamloo","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"87","doi-asserted-by":"publisher","first-page":"105089","DOI":"10.1016\/j.nbd.2020.105089","article-title":"Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer's Disease.","volume":"14","author":"Shamloo","year":"2020","journal-title":"Neurobiol Dis"},{"key":"88","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2165\/00044011-200121090-00004","article-title":"Nicergoline in the treatment of mild-to-moderate Alzheimer\u2019s disease.","volume":"2","author":"Battaglia","year":"2001","journal-title":"Clin Drug Investig"},{"key":"89","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.","volume":"4","author":"Song","year":"2004","journal-title":"Neuron"},{"key":"90","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1161\/01.STR.0000143452.85382.d1","article-title":"RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier.","volume":"3","author":"Zlokovic","year":"2004","journal-title":"Stroke"},{"key":"91","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.1194516","article-title":"Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.","volume":"33","author":"Jucker","year":"2010","journal-title":"Science"},{"key":"92","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0002-9440(10)62995-1","article-title":"Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls.","volume":"16","author":"Van Broeckhoven","year":"2005","journal-title":"Am J Pathol"},{"key":"93","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.","volume":"1","author":"Carare","year":"2008","journal-title":"Brain Pathol"},{"key":"94","doi-asserted-by":"publisher","first-page":"a011452","DOI":"10.1101\/cshperspect.a011452","article-title":"Neurovascular dysfunction and faulty amyloid \u03b2-peptide clearance in Alzheimer disease.","volume":"2","author":"Zlokovic","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"95","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.mn.7800212","article-title":"Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model.","volume":"1","author":"Jefferies","year":"2003","journal-title":"Microcirculation"},{"key":"96","doi-asserted-by":"publisher","first-page":"14908","DOI":"10.3390\/ijms140714908","article-title":"Proteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer's disease.","volume":"1","author":"Rohn","year":"2013","journal-title":"Int J Mol Sci"},{"key":"97","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s40478-020-01076-4","article-title":"Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer's disease.","volume":"8","author":"Koronyo-Hamaoui","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"98","doi-asserted-by":"publisher","first-page":"12906","DOI":"10.1038\/s41598-017-13349-5","article-title":"Altered neurovascular coupling as measured by optical imaging: a biomarker for Alzheimer's disease.","volume":"7","author":"Grimmer","year":"2017","journal-title":"Sci Rep"},{"key":"99","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13195-017-0239-9","article-title":"Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer's disease.","volume":"9","author":"Graham","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"100","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.dadm.2019.03.006","article-title":"Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?","volume":"1","author":"Bouwman","year":"2019","journal-title":"Alzheimers Dement (Amst)"},{"key":"101","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13195-020-00724-0","article-title":"Retinal microvasculature dysfunction is associated with Alzheimer's disease and mild cognitive impairment.","volume":"1","author":"Schmetterer","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"102","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/jpm10040231","article-title":"Ocular Vascular Changes in Mild Alzheimer's Disease Patients: Foveal Avascular Zone, Choroidal Thickness, and ONH Hemoglobin Analysis.","volume":"1","author":"Ram\u00edrez","year":"2020","journal-title":"J Pers Med"},{"key":"103","doi-asserted-by":"publisher","first-page":"572337","DOI":"10.3389\/fnagi.2020.572337","article-title":"Afferent and Efferent Visual Markers of Alzheimer's Disease: A Review and Update in Early Stage Disease.","volume":"1","author":"Balcer","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"104","doi-asserted-by":"publisher","first-page":"2515841420950508","DOI":"10.1177\/2515841420950508","article-title":"OCTA in neurodegenerative optic neuropathies: emerging biomarkers at the eye-brain interface.","volume":"1","author":"Saeedi","year":"2020","journal-title":"Ther Adv Ophthalmol"},{"key":"105","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/micc.12186","article-title":"Restoration of cerebral and systemic microvascular architecture in APP\/PS1 transgenic mice following treatment with Liraglutide\u2122.","volume":"2","author":"Mitchell","year":"2015","journal-title":"Microcirculation"},{"key":"106","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.expneurol.2017.10.023","article-title":"Pericyte implantation in the brain enhances cerebral blood flow and reduces amyloid-\u03b2 pathology in amyloid model mice.","volume":"30","author":"Kanekiyo","year":"2018","journal-title":"Exp Neurol"},{"key":"107","doi-asserted-by":"publisher","first-page":"104","DOI":"10.12779\/dnd.2017.16.4.104","article-title":"Changes in Regional Cerebral Perfusion after Nicergoline Treatment in Early Alzheimer's Disease: A Pilot Study.","volume":"1","author":"Song","year":"2017","journal-title":"Dement Neurocogn Disord"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T10:53:24Z","timestamp":1632135204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":107,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2021,9,15]]}},"alternative-id":["203482","34479211"],"URL":"https:\/\/doi.org\/10.18632\/aging.203482","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]}}}